Prostate cancer is recognized as the leading cause of malignancy-related incidence and mortality in the male population. The treatment regimens have long-term effects detrimental to the patient's quality of life. Hence, this review was aimed to determine the overall HRQOL and its associated among prostate cancer patients.
Methods
The review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The databases searched were PubMed, Embase, Google Scholar and Cumulative Index to the Nursing and Allied Literature (CINAHL), which provided articles that were critically examined, yielding 52 studies that met the inclusion criteria for the systematic review.
Results
Out of 52 studies, 30 studies reported poor overall HRQOL in various domains after prostate cancer treatment. Contrastingly, 15 studies reported good overall quality of life after treatment. Among the various domains, sexual function was the most grossly affected functional score by the treatment modalities of prostate cancer. Nonetheless, seven studies showed that the absence of a significant change in the overall quality of life after treatment. According to the studies, older age, comorbidities, higher clinical stage, higher Gleason score, greater cancer severity, African American race, impaired mental health, neoadjuvant hormonal therapy and lower level of education were the major poor predictors of HRQOL among prostate cancer patients.
Conclusion
The overall HRQOL in prostate cancer patients was generally poor in various functional domains after treatment. Among the various domains, sexual function was the most grossly affected functional score by the treatment modalities of prostate cancer.
BrayFFerlayJSoerjomataramI, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2018;
68: 394–424.
2.
BellarditaLRancatiTAlvisiMF, et al.
Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol2013;
64: 30–36.
3.
GattaGMalloneSvan der ZwanJM, et al.
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol2014;
15: 23–34.
4.
O’LearyEDrummondFJGavinA, et al.
Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate’s egg. Qual Life Res2015;
24: 2219–2230.
5.
SharpLDeadySGallagherP, et al.
The magnitude and characteristics of the population of cancer survivors: using populationbased estimates of cancer prevalence to inform service planning for survivorship care. BMC Cancer2014;
14: 767.
6.
SiegelRDeSantisCVirgoK, et al.Cancer treatment and survivorship statistics, 2012.CA Cancer J Clin2012;
62: 220–241.
7.
JemalACenterMMDeSantisC, et al.Global patterns of cancer incidence and mortality rates and trends.Cancer Epidemiol Biomarkers Prev2010;
19: 1893–1907.
8.
RnicKLindenWTudorI, et al.Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments.Prostate Cancer Prostatic Dis2013;
16: 111–122.
9.
van AndelGBottomleyAFossåSD, et al.An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer2008;
44: 2418–2424.
10.
RammantEOstPSwimbergheM, et al.Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial.Strahlentherapie und Onkol2019;
195: 393–401.
11.
HuangYTLiCCChouYH, et al.Health-related quality of life of exposed versus non-exposed androgen deprivation therapy patients with prostate cancer: a cross-sectional study. Int J Clin Pharm2019;
41: 993–1003.
12.
RathHMUllrichAOttoU, et al.
Psychosocial and physical outcomes of in- and outpatient rehabilitation in prostate cancer patients treated with radical prostatectomy.Support Care Cancer2016;
24: 2717–2726.
13.
SchaakeWDe GrootMKrijnenWP, et al.Quality of life among prostate cancer patients: a prospective longitudinal population-based study. Radiother Oncol2013;
108: 299–305.
14.
MillerKDSiegelRLLinCC, et al.Cancer treatment and survivorship statistics, 2016.CA Cancer J Clin2016;
66: 271–289.
15.
AdamSFellerARohrmannS, et al.Health-related quality of life among long-term (≥5years) prostate cancer survivors by primary intervention: a systematic review.Health Qual Life Outcomes2018;
16: 22.
16.
DrummondFJKinnearHO’LearyE, et al.Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.J Cancer Surviv2015;
117: 1123–1135.
17.
HeidenreichABastianPJBellmuntJ, et al.
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent – update 2013. Eur Urol2014;
65: 124–137.
18.
ChenCChenZWangK, et al.Comparisons of health-related quality of life among surgery and radiotherapy for localized prostate cancer: a systematic review and meta-analysis.Oncotarget2017;
8: 99057–99065.
19.
FreedlandSJ.Screening, risk assessment, and the approach to therapy in patients with prostate cancer.Cancer2011;
117: 1123–1135.
20.
StattinPHolmbergEJohanssonJE, et al.Outcomes in localized prostate cancer: national prostate cancer register of Sweden follow-up study. J Natl Cancer Inst2010;
102: 950–958.
21.
StewartLAClarkeMRoversM, et al.Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement.J Am Med Assoc2015;
313: 1657.
WellsGSheaBO’ConnellD, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, www.ohri.ca/programs/clinical_epidemiology/oxford.asp (2000, accessed 03 September 2020).
24.
GacciMLapiniASerniS, et al.
Predictors of quality of life after radical treatment for prostate cancer.Urol Int2008;
80: 231–236.
25.
KimSHSeongDHYoonSM, et al.Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy.Eur J Oncol Nurs2017;
30: 84–90.
26.
LehtoUSOjanenMVäkeväA, et al.Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer.Qual Life Res2019;
28: 677–686.
27.
KaoYLTsaiYSOuFY, et al.
Determinants of quality of life in prostate cancer patients: a single institute analysis. Urol Sci2015;
26: 254–258.
28.
Rondorf-KlymLMCollingJ.Quality of life after radical prostatectomy. Oncol Nurs Forum2003;
30: 24–32.
29.
JayadevappaRJohnsonJCChhatreS, et al.Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients.Cancer2007;
109: 2229–2238.
30.
IsaMRMingMFAbdul RazackAH, et al.
General health related quality of life and associated factors among prostate cancer patients in two tertiary medical centers in Kuala Lumpur, Malaysia: a cross-sectional study.Asian Pac J Cancer Prev2012;
13: 5999–6004.
31.
SchaeferJWWelzelGTrojanL, et al.
Long-term health-related quality-of-life outcomes after permanent prostate brachytherapy. Onkologie2008;
31: 599–603.
32.
LamKChowEZhangL, et al.
Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer2013;
21: 3021–3030.
33.
YamamotoSFujiiYMasudaH, et al.
Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer. Qual Life Res2014;
23: 1641–1650.
34.
TakizawaIHaraNNishiyamaT, et al.
Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification. Asian J Androl2009;
11: 283–290.
35.
LevELEllerLSGejermanG, et al.
Quality of life of men treated with brachytherapies for prostate cancer. Heal Qual Life Outcomes2004;
2: 28.
36.
ChenSSChengTCChiuLP, et al.
Predictors for lower urinary tract symptoms and the urinary specific quality of life in prostate cancer patients: one-year follow-up.J Chin Med Assoc2019;
82: 482–487.
37.
SullivanPWNelsonJBMulaniPM, et al.
Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Qual Life Res2006;
15: 1297–1306.
38.
HarjuERantanenAHelminenM, et al.
Health-related quality of life in patients with prostate cancer and their spouses: results from a longitudinal study.Eur J Oncol Nurs2018;
37: 51–55.
39.
EllerLSLevELGejermanG, et al.
Prospective study of quality of life of patients receiving treatment for prostate cancer. Nurs Res2006;
55: S28–S36.
40.
HollenbeckBKDunnRLWeiJT, et al.
Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy. Urology2002;
59: 480–484.
41.
MoinpourCMHaydenKAUngerJM, et al.
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.J Clin Oncol2008;
26: 112–120.
42.
Al-BatranSEHozaeelWTauchertFK, et al.
The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax). Ann Oncol2015;
26: 1244–1248.
43.
BradleyEBBissonetteEATheodorescuD.Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.BJU Int2004;
94: 1003–1009.
44.
MelotekJMLiaoCLiauwSL.Quality of life after post-prostatectomy intensity modulated radiation therapy: pelvic nodal irradiation is not associated with worse bladder, bowel, or sexual outcomes.PLoS One2015;
10: e0141639.
45.
PunnenSCowanJEChanJM, et al.Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.Eur Urol2015;
68: 600–608.
46.
ChenRCClarkJATalcottJA.Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.J Clin Oncol2009;
27: 3916–3922.
47.
PinkawaMPirothMDAsadpourB, et al.
Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis.Strahlenther Onkol2009;
185: 101–108.
48.
LevELEllerLSGejermanG, et al.
Quality of life of men treated for localized prostate cancer: outcomes at 6 and 12 months.Support Care Cancer2009;
17: 509–517.
49.
KasperzykJLShappleyWVKenfieldSA, et al.
Watchful waiting and quality of life among prostate cancer survivors in the Physicians’ Health Study. J Urol2011;
186: 1862–1867.
50.
van GysenKLKneeboneABGuoL, et al.
Health-related quality of life using intensity-modulated radiation therapy for post-prostatectomy radiotherapy.J Med Imaging Radiat Oncol2013;
57: 89–96.
51.
LingDCChenKSBenoitRM, et al.
Long-term patient-reported rectal bleeding and bowel-related quality of life after Cs-131 prostate brachytherapy. Int J Radiat Oncol Biol Phys2019;
104: 622–630.
52.
JohanssonESteineckGHolmbergL, et al.
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.Lancet Oncol2011;
12: 891–899.
53.
FossåSDDahlAA.Global quality of life after curative treatment for prostate cancer: what matters? A study among members of the Norwegian Prostate Cancer Patient Association. Clin Genitourin Cancer2015;
13: 518–524.
54.
JayadevappaRBloomBSChhatreS, et al.
Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.J Urol2005;
174: 1059–1064.
55.
MarzoukSNaglieGTomlinsonG, et al.
Impact of androgen deprivation therapy on self-reported cognitive function in men with prostate cancer.J Urol2018;
200: 327–334.
56.
PotoskyALLeglerJAlbertsenPC, et al.
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst2000;
92: 1582–1592.
57.
KeoghJWShepherdDKrägelohCU, et al.
Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy.N Z Med J2010;
123: 20–29.
58.
KyrdalenAEDahlAAHernesE, et al.
A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.BJU Int2013;
111: 221–232.
59.
KimuraMBañezLLSchroeckFR, et al.
Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy. J Sex Med2011;
8: 2935–2943.
60.
LinkRESuLMSullivanW, et al.
Health related quality of life before and after laparoscopic radical prostatectomy.J Urol2005;
173: 175–179.
61.
GoineauACampionLD’AillièresB, et al.
Comprehensive geriatric assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.PLoS One2018;
13: e0194173.
62.
MickevičienėAVanagasGUlysA, et al.
Factors affecting health-related quality of life in prostate cancer patients. Scand J Urol Nephrol2012;
46: 180–187.
63.
WrightJLLinDWCowanJE, et al.
Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis2008;
11: 67–73.
64.
SandaMGDunnRLMichalskiJ, et al.
Quality of life and satisfaction with outcome among prostate-cancer survivors.N Engl J Med2008;
358: 1250–1261.
65.
BanerjiJSHurwitzLMCullenJ, et al.
A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.Urol Oncol2017;
35: 234–242.
66.
FicarraVNovaraGGalfanoA, et al.
Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36).BJU Int2006;
97: 274–278.
67.
HuangGJSadetskyNPensonDF.Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol2010;
183: 2206–2212.
68.
QueenanJAFeldman-StewartDBrundageM, et al.Social support and quality of life of prostate cancer patients after radiotherapy treatment.Eur J Cancer Care2010;
19: 251–259.
69.
YangBKYoungMDCalingaertB, et al.
Prospective and longitudinal patient self-assessment of health-related quality of life following radical perineal prostatectomy.J Urol2004;
172: 264–268.
70.
DacalKSereikaSMGreenspanSL.Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am Geriatr Soc2006;
54: 85–90.
71.
HaackMKramerSSeidelG, et al.
Quality of life and fear of disease progression are associated with aspects of health literacy in men with prostate cancer from Germany.Support Care Cancer2020;
28: 2283–2292.
72.
LinYHLinVCYuTJ, et al.Comparison of health-related quality of life between subjects treated with radical prostatectomy and brachytherapy.J Clin Nurs2012;
21: 1906–1912.
73.
EfficaceFBottomleyAVan AndelG.Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials.Cancer2003;
97: 377–388.
74.
FaurySFoucaudJ.Health-related quality of life in cancer patients treated with immune checkpoint inhibitors: a systematic review on reporting of methods in randomized controlled trials.PLoS One2020;
15: e0227344.
75.
Van OostromSHPicavetHSJVan GelderBM, et al.
Multimorbidity and comorbidity in the Dutch population-data from general practices.BMC Public Health2012;
12: 715.
76.
TewariAKGoldHTDemersRY, et al.
Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer.Urology2009;
73: 624–630.
77.
HellenthalNJParikh-PatelABauerK, et al.
Men of higher socioeconomic status have improved outcomes after radical prostatectomy for localized prostate cancer. Urology2010;
76: 1409–1413.
78.
AizerAAChenMHMcCarthyEP, et al.
Marital status and survival in patients with cancer. J Clin Oncol2013;
32: 3869–3876.
